Kyle Kaltwasser

Kyle Kaltwasser practices at Summit Health in Bend, Oregon.

Kyle Kaltwasser's NPI, 1750769949, was assigned on May 8, 2015. Kyle Kaltwasser graduated from UTMB Health in 2015. Kyle Kaltwasser's Texas license number on file is R8921.

Kyle Kaltwasser's primary practice is Summit Health, at 1501 Ne Medical Center Dr, Bend, OR 97701. The practice phone is (541) 382-2811.

Kyle Kaltwasser's primary practice is Summit Health in Bend, Oregon. Kyle Kaltwasser is also affiliated with St. Charles Bend. The medical group on file is Summit Health. Dmand AI also links Kyle Kaltwasser to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kyle Kaltwasser practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Kyle Kaltwasser's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Kyle Kaltwasser is board certified in dermatology by the American Board of Dermatology. Dmand AI has Kyle Kaltwasser's licenses on file in 4 states: Texas, Utah, Colorado and Oregon.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Kyle Kaltwasser treats.

CMS data shows 4,593 Medicare services from Kyle Kaltwasser across 20 procedure codes in 2024, for 790 Medicare patients. Medicare paid $179,616 for them. Every service was in an office.

CMS counts 790 Medicare patients who saw Kyle Kaltwasser in 2024. The largest group is 65 to 74, with 372 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kyle Kaltwasser's median patient age at 67, with 40% women.

In 2024, Kyle Kaltwasser wrote 1,144 Medicare Part D claims for 443 patients. 94% of them were for generic drugs. CMS names the drug for 988 of them, across 23 drugs with 11 or more claims each, at $145,696 in total drug cost. In 2023, CMS named 1,013 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Kyle Kaltwasser for performance year 2024, reported individually. Kyle Kaltwasser accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,175 procedures of removal of skin lesions by Kyle Kaltwasser, more than 94% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Kyle Kaltwasser, published from 2014 to 2019. 2015 was the busiest year, with 2. The most frequent topics are Breast Implantation and Pectoralis Muscles. Kyle Kaltwasser has published most often in Aesthet Surg J. Kyle Kaltwasser's most frequent co-authors are Clayton L. Moliver, MD, Ludwik Krzysztof Branski, MD and Alexander Chase Castillo, MD.

CMS Open Payments shows 82 general payments to Kyle Kaltwasser from 15 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 89% of the total. Abbvie Inc. paid the most, $1,019.

Kyle Kaltwasser graduated from UTMB Health in 2015.

Kyle Kaltwasser is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.